Mallika Ann Ambat, Actelion Pharmaceuticals
Mallika Ann Ambat, Senior Director, Market Research, Actelion Pharmaceuticals
Mallika Ann Ambat is the Director, US Market Research Lead at Actelion. She has over twenty years of hands-on pharmaceutical and bio-tech experience.
She started her career at Pharma companies such as Hoffman-La Roche and Schering-Plough on the East Coast, and most recently worked at bio-tech companies, including Agouron-Pfizer (formerly in San Diego) and Actelion in the Bay Area.
She has extensive market research experience with key stakeholders (HCPs, patients and payors) and has worked in both primary care and specialty markets. At Actelion, she works in Pulmonary Arterial Hypertension, MF-CTCL and Gaucher’s Disease.
In her role at Actelion, she collaborates closely with her sales analytic colleagues to optimize decisions for business development, portfolio planning and new product commercialization.
Mallika earned an MBA degree from St. Joseph’s University in Philadelphia and has a B.S. in Life Sciences.
Leilani Berchesi, Abbott
Leilani Berchesi, Director of Global Market Insights, Abbott’s Diabetes Care
Leilani Berchesi is Director of Global Market Insights at Abbott’s Diabetes Care division. In this role, she generates deep insights about consumers, healthcare professionals, and payors that inform strategic planning, product innovation, and commercial tactics. She has also held roles both at Abbott and at other organizations focusing on strategic planning, analytics, insights generation, and brand marketing. She is passionate about understanding the hidden influences and motivations behind a person’s thoughts, perceptions, and actions and using those to help customers experience life more fully.
Meghna Chowdary, Portola Pharmaceuticals
Meghna Chowdary, Vice President, Commercial Operations & Analytics, Portola Pharmaceuticals
Meghna is the Vice President, Commercial Operations & Analytics at Portola Pharmaceuticals. Prior to that, she lead Strategic Insights and Analytics at Relypsa. In that role, she served as a strategic advisor to executive leadership, providing insights on product performance and contributing to portfolio planning. She was previously at Genentech for 10 years, where her last role was leading the Market Planning group supporting the Oncology business unit. The group was responsible for driving strategic planning efforts for 13 in-line products and late-stage molecules. Prior to Genentech, she worked at a boutique hospital strategic planning firm that assessed how new technologies would change the delivery of healthcare services. She holds a BS in Biology from Stanford and an MBA from Wharton.
Michael Gerhold, Neurocrine Biosciences
Michael Gerhold, Head of Commercial Analytics, Neurocrine Biosciences
Michael is the Head of Commercial Analytics at Neurocrine Biosciences. In his role, Michael oversees a team that provides market research and analytics support for newly launched INGREZZA as well as life cycle management opportunities.
Prior to joining Neurocrine Biosciences, Michael was at Otsuka Pharmaceuticals where he provided market research insights to the successful HCP and DTC launch of Rexulti, a novel antipsychotic. Michael has over 15 years of experience working in a variety of roles in market research, marketing, analytics and forecasting supporting in-line brand teams, life cycle management, and business development.
Michael holds a MBA and Master of Science in Biomedical Engineering from Purdue University and a BS in Biophysics from University of California San Diego. Michael is originally from San Diego, California.
Sharon Grehan, Gilead Sciences
Sharon Grehan, Ph.D., Executive Director, Marketing Sciences, Gilead Sciences
Sharon Grehan, Ph.D., is an Executive Director at Gilead Sciences (located in Foster City, CA). She joined Gilead 11 years ago and leads the US Marketing Sciences group across the entire company portfolio. Her professional track record is enhanced by a strong academic foundation and more than 20 years of experience in the scientific/biotechnology sector.
Prior to joining Gilead, Dr. Grehan was the Senior Managing Consultant at WWMR for 5 years, a biotech-focused market research and strategic consulting company located in San Mateo, CA.
Prior to joining industry, Dr. Grehan completed a post-doctoral fellowship at the Gladstone Institutes in San Francisco and became a Research Scientist and Group Manager of the research laboratory after two years. She has coauthored over 10 scientific publications in the molecular biology arena, published in Journal of Neuroscience, Journal of Immunology, European Journal of Immunology, Journal of Rheumatology, and Journal of Investigative Dermatology.
Dr. Grehan has a B.Sc. in Microbiology and a M.Sc. in Biotechnology from the National University of Ireland, and a Ph.D. in Genetic Engineering from Trinity College in Dublin, Ireland.
Rahim Hirji, Omeros Corporation
Rahim Hirji, Director, Marketing and New Product Planning, Omeros Corporation
Carly Loeb, Dermira
Carly Loeb, Ph.D., Sr. Director, Market Insights & Operations, Dermira
Heather Stamper, Genentech
Heather Stamper, Director, MA&S BioOncology, Genentech